Limb Lengthening Research Papers
CLINICAL RESEARCH
Cosmetic Lower Limb Lengthening by Ilizarov Apparatus: What Are The Risks?
Konstantin I. Novikov PhD, Koushik N. Subramanyam MS,
Serghei O. Muradisinov MD, Olga S. Novikova MD,
Elina S. Kolesnikova MD
Received: 6 January 2014 / Accepted: 23 June 2014 / Published online: 3 September 2014
Page 3 - Introduction Continued
We believe that optimum lengthening of the lower limb
can be done only up to 5 to 7 cm, beyond which outcome
may be suboptimal in view of cosmesis (trunk-limb proportions)
[4, 19], altered biomechanics, and soft tissue
function [10]. Therefore, most lengthenings were planned
only for the tibial segment, bilaterally simultaneously,
either monofocally (\5 cm) or bifocally ([5 cm to
reduce the duration of fixator [18]). However, for patients
who wanted more lengthening, we planned additional
lengthening of the femoral segment. For the tibia, we used
the standard three-ring construct for monofocal and bifocal
lengthenings, with more wires for bifocal lengthening. The
tibial corticotomy was below the tibial tuberosity for
monofocal lengthening and also at the supramalleolar level
for bifocal lengthening. A fibular osteotomy was done at
the junction of the middle and distal thirds. Bifocal tibial
corticotomies were accompanied by two level fibular osteotomies
during the 1980s and 1990s. Later the proximal
fibular osteotomy was avoided as it was found to be
unnecessary and posed the possibility of injury to the
common peroneal nerve. The femur was lengthened at the
supracondylar level using an assembly consisting of two
rings and a single arch with wires distally and half pins
proximally.
Distraction started on the seventh postoperative day.
Monofocal lengthening was commenced at a rate of 0.75 to
1 mm/day over three to four fractions and gradually
increased to 1 to 1.5 mm/day over four to six fractions as
guided by clinicoradiographic assessment of new bone
formation. We observed that the rate could be increased
slightly more than 1 mm/day for teenagers and could be
maintained only at less than 1 mm/day for patients in the
older age categories. The rate for bifocal distraction was
1.25 to 1.5 mm/day per bone over three to four fractions,
with distraction at one site being greater than at the other
site in the beginning. Distraction gradually become equal,
and then gradually reversed toward the end of distraction.
ROM exercises of the joints (as much as the fixator
allowed) and weightbearing walking with use of axillary
crutches were encouraged as much as tolerated from the
second postoperative day. All patients were monitored as
inpatients until removal of the fixator. Radiographs were
taken every 2 weeks to assess the quality of regenerate,
lengthening, and occurrence of any deformity. After gaining
sufficient length by distraction, the fixators were left in
place for the necessary time to allow consolidation of the
regenerate. The decision to remove the fixator was based
on a satisfactory stress test after removing the connecting
rods and satisfactory consolidation observed on the radiographs
as evidenced by complete bone bridging in at least
two projections. After fixator removal, the patients wore a
cast extending from the thigh to the supramalleolar region
for 2 to 4 weeks as determined during stress testing at the
time of fixator removal. We did not use a removable
orthosis for any patient because of unavailability.
We looked for the incidence of pin tract and soft tissue
infections, common peroneal neuropathy, and assessment
of knee and ankle ROM during and after external fixation to
assess for soft tissue complications. For bone-related complications
we watched for the incidence of osteomyelitis
during treatment, and did clinicoradiologic monitoring for
knee and ankle congruity to rule out any subluxations, speed
of regeneration, incidence of any deformity, or fracture of
regenerate during and after external fixation. We recorded
how each of these challenges was approached or treated and
the final outcome. We also recorded all technical challenges
and how they were managed.
The patients were followed up every 3 months for
1 year and then yearly thereafter. Assessment was for
patient satisfaction, axial deviation, ROM of the joints, foot
and ankle deformities, limb length discrepancy, infection,
pain, and functional status. A physician-based outcome
score developed by one of us (KIN) was used to assess
outcome: excellent = planned increase in the length of
limb segments achieved with good preservation of body
proportions and function in the absence of deformity and
joint stiffness; good = planned extension of the limbs
achieved against trunk-limb proportions, or partial restriction
of limb function, in the form of abnormal gait, 3 degrees to 5 degrees
axial deviation, or 5 degrees to 10 degrees limitation of joint movement;
satisfactory = lengthening of limbs achieved up to 75% of
the planned value or presence of 5 degrees to 10 degrees axial deviation
or 10 degrees to 15 degrees limitation of joint movement; and unsatisfactory
= lengthening achieved to less than 75% of the
planned value or presence of axial deviation greater than
10 degrees or limitation of joint movement greater than 15 degrees.
Patient-based outcomes were measured in terms of
patient satisfaction and improvement of self-esteem.
Patient-related outcome was measured by asking the
patient at the completion of treatment whether they were satisfied (yes/no), whether the procedure led to improvement
of their self-esteem (yes/no), whether they would
undergo the procedure again (yes/no), and whether they
would recommend it to someone with subjective feelings
of short stature (yes/no).